NASDAQ : RCEL
AVITA Medical, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 16.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 516.79M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
AVITA Medical, Inc. (RCEL) reported revenue of 75.63M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 75.63M | 71.61M | 64.25M | 50.14M | 34.42M | 33.02M |
| Cost of Revenue | 13.95M | 12.79M | 9.09M | 7.78M | 6.04M | 6.10M |
| Gross Profit | 61.68M | 58.82M | 55.16M | 42.36M | 28.38M | 26.92M |
| Selling, General & Admin | 76.75M | 80.51M | 91.39M | 65.62M | 45.24M | 37.92M |
| Research & Development | 20.15M | 20.84M | 20.36M | 20.82M | 13.86M | 15.67M |
| Other Operating Expenses | -1.43M | -3.21M | -1.59M | |||
| Operating Expenses | 96.90M | 101.35M | 111.75M | 85.02M | 55.88M | 52.00M |
| Operating Income | -35.22M | -42.53M | -56.59M | -42.66M | -27.50M | -25.08M |
| Interest Expense | -7.91M | -8.30M | -5.36M | -1.92M | -16.00K | -29.00K |
| Interest & Investment Income | 600.00K | 900.00K | 2.70M | 3.10M | ||
| Currency Exchange Gain (Loss) | -17.00K | -17.00K | -21.00K | -15.00K | ||
| Other Non Operating Income (Expenses) | 179.00K | 2.78M | -16.00K | -427.00K | 892.00K | 47.00K |
| EBT Excluding Unusual Items | -42.36M | -47.18M | -59.29M | -41.91M | -26.63M | -25.06M |
| Gain (Loss) on Sale of Assets | 9.40M | |||||
| Asset Writedown | -42.00K | |||||
| Other Unusual Items | -700.00K | -1.40M | -2.50M | -2.80M | ||
| Pretax Income | -43.06M | -48.58M | -61.79M | -35.31M | -26.63M | -25.10M |
| Income Tax Expense | 21.00K | 11.00K | 54.00K | 66.00K | 36.00K | 42.00K |
| Earnings From Continuing Operations | -43.08M | -48.59M | -61.84M | -35.38M | -26.66M | -25.14M |
| Net Income | -43.08M | -48.59M | -61.84M | -35.38M | -26.66M | -25.14M |
| Net Income to Common | -43.08M | -48.59M | -61.84M | -35.38M | -26.66M | -25.14M |
| Shares Outstanding (Basic) | 29.98M | 27.86M | 25.88M | 25.33M | 25.00M | 24.36M |
| Shares Outstanding (Diluted) | 29.98M | 27.86M | 25.88M | 25.33M | 25.00M | 24.36M |
| EPS (Basic) | -1.44 | -1.74 | -2.39 | -1.40 | -1.07 | -1.03 |
| EPS (Diluted) | -1.44 | -1.74 | -2.39 | -1.40 | -1.07 | -1.03 |
| Free Cash Flow | -24.61M | -32.20M | -58.11M | -39.39M | -19.54M | -18.52M |
| Free Cash Flow Per Share | -0.82 | -1.16 | -2.25 | -1.55 | -0.78 | -0.76 |
| Gross Margin | 81.56% | 82.13% | 85.85% | 84.48% | 82.45% | 81.52% |
| Operating Margin | -46.56% | -59.40% | -88.08% | -85.07% | -79.91% | -75.93% |
| Profit Margin | -56.96% | -67.85% | -96.25% | -70.56% | -77.47% | -76.13% |
| Free Cash Flow Margin | -32.54% | -44.97% | -90.44% | -78.56% | -56.77% | -56.09% |
| EBITDA | -32.76M | -40.24M | -55.47M | -42.02M | -26.94M | -24.40M |
| EBITDA Margin | -43.32% | -56.19% | -86.33% | -83.81% | -78.26% | -73.89% |
| D&A For EBITDA | 2.45M | 2.29M | 1.13M | 632.00K | 568.00K | 673.00K |
| EBIT | -35.22M | -42.53M | -56.59M | -42.66M | -27.50M | -25.08M |
| EBIT Margin | -46.56% | -59.40% | -88.08% | -85.07% | -79.91% | -75.93% |
| Revenue as Reported | 75.63M | 71.61M | 64.25M | 50.14M | ||
| Advertising Expenses | 492.00K | 539.00K | 398.00K | 216.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.14M | 10.24M | 14.05M | 22.12M | 18.16M | 55.51M |
| Short-Term Investments | 2.00M | 7.94M | 21.84M | 66.94M | 61.18M | 29.65M |
| Cash & Short-Term Investments | 11.13M | 18.18M | 35.88M | 89.06M | 79.34M | 85.16M |
| Accounts Receivable | 9.87M | 9.09M | 11.79M | 7.69M | 3.53M | 3.43M |
| Other Receivables | 19.00K | 21.00K | 121.00K | 227.00K | 1.18M | 87.00K |
| Receivables | 9.89M | 9.11M | 11.91M | 7.92M | 4.71M | 3.51M |
| Inventory | 5.29M | 6.93M | 7.27M | 5.60M | 2.12M | 2.13M |
| Prepaid Expenses | 2.09M | 1.27M | 1.94M | 1.43M | 921.00K | 1.12M |
| Restricted Cash | 201.00K | |||||
| Other Current Assets | 362.00K | 2.00K | ||||
| Total Current Assets | 28.39M | 35.49M | 57.00M | 104.01M | 87.46M | 92.13M |
| Property, Plant & Equipment | 10.33M | 11.53M | 13.59M | 4.32M | 2.05M | 2.81M |
| Long-Term Investments | 6.93M | 19.69M | ||||
| Other Intangible Assets | 5.25M | 5.64M | 5.57M | 487.00K | 465.00K | 443.00K |
| Long-Term Deferred Charges | 504.00K | |||||
| Other Long-Term Assets | 3.80M | 3.73M | 3.55M | 2.83M | 1.36M | 438.00K |
| Total Assets | 47.78M | 56.39M | 79.71M | 111.64M | 98.26M | 116.02M |
| Accounts Payable | 6.42M | 8.96M | 6.29M | 3.79M | 3.00M | 2.71M |
| Accrued Expenses | 9.33M | 8.09M | 12.54M | 8.14M | 6.70M | 5.36M |
| Current Portion of Long-Term Debt | 46.66M | 42.98M | ||||
| Current Portion of Leases | 929.00K | 900.00K | 895.00K | 612.00K | 720.00K | |
| Current Unearned Revenue | 33.00K | 33.00K | 33.00K | 33.00K | ||
| Other Current Liabilities | 6.27M | 1.68M | 386.00K | 338.00K | 378.00K | 355.00K |
| Total Current Liabilities | 68.71M | 62.68M | 20.16M | 13.20M | 10.69M | 9.15M |
| Long-Term Debt | 42.24M | 39.81M | ||||
| Long-Term Leases | 1.82M | 2.13M | 2.84M | 1.70M | 306.00K | 918.00K |
| Long-Term Unearned Revenue | 273.00K | 290.00K | 324.00K | 357.00K | 698.00K | 952.00K |
| Other Long-Term Liabilities | 4.81M | 7.94M | 9.64M | 7.51M | 1.83M | 375.00K |
| Total Liabilities | 75.61M | 73.04M | 75.21M | 62.58M | 13.52M | 11.39M |
| Common Stock | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Additional Paid-In Capital | 399.54M | 394.41M | 367.57M | 350.04M | 339.82M | 332.48M |
| Retained Earnings | -426.68M | -408.40M | -359.81M | -297.97M | -262.59M | -235.92M |
| Comprehensive Income & Other | -707.00K | -2.66M | -3.26M | -3.02M | 7.50M | 8.06M |
| Shareholders' Equity | -27.84M | -16.65M | 4.50M | 49.06M | 84.74M | 104.62M |
| Total Liabilities & Equity | 47.78M | 56.39M | 79.71M | 111.64M | 98.26M | 116.02M |
| Total Debt | 48.48M | 46.05M | 45.98M | 42.41M | 918.00K | 1.64M |
| Net Cash (Debt) | -37.35M | -27.86M | -10.10M | 46.65M | 85.35M | 103.21M |
| Net Cash Per Share | -1.25 | -1.00 | -0.39 | 1.84 | 3.41 | 4.24 |
| Filing Date Shares Outstanding | 30.93M | 30.63M | 26.36M | 25.71M | 25.30M | 24.93M |
| Total Common Shares Outstanding | 30.93M | 30.57M | 26.35M | 25.68M | 25.21M | 24.93M |
| Working Capital | -40.32M | -27.19M | 36.84M | 90.81M | 76.77M | 82.99M |
| Book Value Per Share | -0.90 | -0.54 | 0.17 | 1.91 | 3.36 | 4.20 |
| Tangible Book Value | -33.09M | -22.30M | -1.07M | 48.57M | 84.28M | 104.18M |
| Tangible Book Value Per Share | -1.07 | -0.73 | -0.04 | 1.89 | 3.34 | 4.18 |
| Machinery | 6.14M | 6.28M | 6.20M | 3.02M | 1.97M | 1.88M |
| Construction In Progress | 17.00K | 442.00K | 87.00K | 258.00K | 29.00K | |
| Leasehold Improvements | 4.88M | 4.88M | 4.61M | 367.00K | 257.00K | 242.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -43.08M | -48.59M | -61.84M | -35.38M | -26.66M | -25.14M |
| Depreciation & Amortization | 2.45M | 2.29M | 1.13M | 632.00K | 568.00K | 673.00K |
| Other Amortization | 53.00K | 53.00K | 341.00K | 338.00K | 296.00K | |
| Loss (Gain) From Sale of Assets | 500.00K | 606.00K | 123.00K | 87.00K | 3.00K | 130.00K |
| Asset Writedown & Restructuring Costs | 42.00K | |||||
| Loss (Gain) From Sale of Investments | -235.00K | -308.00K | -1.67M | -1.36M | -281.00K | 104.00K |
| Stock-Based Compensation | 7.24M | 9.52M | 13.50M | 8.38M | 7.00M | 6.33M |
| Provision & Write-off of Bad Debts | 10.00K | -10.00K | 23.00K | 24.00K | -5.00K | 16.00K |
| Other Operating Activities | 4.88M | 1.80M | 4.49M | -4.16M | 1.15M | 934.00K |
| Change in Accounts Receivable | 1.47M | 3.63M | -4.14M | -4.17M | -395.00K | -1.19M |
| Change in Inventory | 1.86M | -468.00K | -2.16M | -3.69M | -371.00K | -144.00K |
| Change in Accounts Payable | -704.00K | 2.75M | 340.00K | 809.00K | 282.00K | -49.00K |
| Change in Unearned Revenue | -33.00K | -33.00K | -33.00K | -341.00K | -254.00K | 356.00K |
| Change in Other Net Operating Assets | 1.37M | -2.44M | 1.32M | 823.00K | -458.00K | -391.00K |
| Operating Cash Flow | -24.23M | -31.20M | -48.94M | -38.01M | -19.09M | -18.04M |
| Capital Expenditures | -387.00K | -1.00M | -9.17M | -1.38M | -452.00K | -487.00K |
| Sale (Purchase) of Intangibles | -727.00K | -734.00K | -162.00K | -66.00K | -73.00K | -171.00K |
| Investment in Securities | 1.71M | 14.19M | 46.70M | 3.05M | -18.81M | -49.55M |
| Investing Cash Flow | 600.00K | 12.45M | 37.36M | 1.61M | -19.33M | -50.21M |
| Long-Term Debt Issued | 38.76M | |||||
| Total Debt Repaid | -42.98M | -2.00K | ||||
| Net Debt Issued (Repaid) | 6.10M | 38.76M | -2.00K | |||
| Issuance of Common Stock | 15.51M | 15.99M | 3.51M | 1.61M | 900.00K | 69.18M |
| Other Financing Activities | -1.06M | -1.06M | -5.11M | |||
| Financing Cash Flow | 20.55M | 14.94M | 3.51M | 40.37M | 900.00K | 64.06M |
| Foreign Exchange Rate Adjustments | -16.00K | -26.00K | -74.00K | |||
| Net Cash Flow | -3.08M | -3.81M | -8.07M | 3.95M | -37.55M | -4.25M |
| Free Cash Flow | -24.61M | -32.20M | -58.11M | -39.39M | -19.54M | -18.52M |
| Free Cash Flow Margin | -32.54% | -44.97% | -90.44% | -78.56% | -56.77% | -56.09% |
| Free Cash Flow Per Share | -0.82 | -1.16 | -2.25 | -1.55 | -0.78 | -0.76 |
| Levered Free Cash Flow | -13.35M | -18.33M | -32.64M | -24.56M | -9.31M | |
| Unlevered Free Cash Flow | -8.41M | -13.14M | -29.29M | -23.36M | -9.30M | |
| Cash Interest Paid | 5.38M | 4.98M | 5.36M | 1.14M | 15.00K | 29.00K |
| Cash Income Tax Paid | 59.00K | 15.00K | 41.00K | 44.00K | 17.00K | 8.00K |
| Change in Working Capital | 3.96M | 3.44M | -4.68M | -6.57M | -1.20M | -1.42M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 476.58M | 105.87M | 338.19M | 352.28M | 166.38M | 298.61M |
| Enterprise Value | 513.93M | 127.33M | 339.41M | 294.91M | 79.30M | 190.43M |
| Last Close Price | 15.41 | 3.45 | 12.80 | 13.72 | 6.60 | 11.98 |
| PS Ratio | 6.30 | 1.48 | 5.26 | 7.03 | 4.83 | 9.04 |
| PB Ratio | -6.36 | 75.17 | 7.18 | 1.96 | 2.85 | |
| P/TBV Ratio | 7.25 | 1.97 | 2.87 | |||
| EV/Sales Ratio | 6.80 | 1.78 | 5.28 | 5.88 | 2.30 | 5.77 |
| Debt / Equity Ratio | -1.74 | -2.77 | 10.22 | 0.86 | 0.01 | 0.02 |
| Net Debt / Equity Ratio | -1.34 | -1.67 | 2.25 | -0.95 | -1.01 | -0.99 |
| Net Debt / EBITDA Ratio | -1.14 | -0.69 | -0.18 | 1.11 | 3.17 | 4.23 |
| Net Debt / FCF Ratio | -1.52 | -0.86 | -0.17 | 1.18 | 4.37 | 5.57 |
| Asset Turnover | 1.43 | 1.05 | 0.67 | 0.48 | 0.32 | |
| Inventory Turnover | 2.18 | 1.80 | 1.41 | 2.02 | 2.84 | |
| Quick Ratio | 0.31 | 0.43 | 2.37 | 7.35 | 7.86 | 9.70 |
| Current Ratio | 0.41 | 0.57 | 2.83 | 7.88 | 8.18 | 10.07 |
| Return on Equity (ROE) | -230.96% | -52.89% | -28.16% | |||
| Return on Assets (ROA) | -41.56% | -39.06% | -36.97% | -25.40% | -16.05% | |
| Return on Capital Employed (ROCE) | 168.20% | 676.80% | -95.00% | -43.30% | -31.40% | -23.50% |
| Earnings Yield | -9.32% | -45.89% | -18.29% | -10.04% | -16.03% | -8.42% |
| FCF Yield | -5.16% | -30.41% | -17.18% | -11.18% | -11.75% | -6.20% |
| Buyback Yield / Dilution | -14.29% | -7.64% | -2.18% | -1.32% | -2.64% | -7.42% |